Devyser Diagnostics AB (FRA:OL0) Cash-to-Debt : 2.80 (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Devyser Diagnostics AB Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Devyser Diagnostics AB's cash to debt ratio for the quarter that ended in Sep. 2024 was 2.80.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Devyser Diagnostics AB could pay off its debt using the cash in hand for the quarter that ended in Sep. 2024.

The historical rank and industry rank for Devyser Diagnostics AB's Cash-to-Debt or its related term are showing as below:

FRA:OL0' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.39 Med: 4.01 Max: 31.52
Current: 2.8

During the past 7 years, Devyser Diagnostics AB's highest Cash to Debt Ratio was 31.52. The lowest was 0.39. And the median was 4.01.

FRA:OL0's Cash-to-Debt is ranked better than
65.49% of 226 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.99 vs FRA:OL0: 2.80

Devyser Diagnostics AB Cash-to-Debt Historical Data

The historical data trend for Devyser Diagnostics AB's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Devyser Diagnostics AB Cash-to-Debt Chart

Devyser Diagnostics AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.44

0.39

29.14

17.16

3.52

Devyser Diagnostics AB Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash-to-Debt	Get a 7-Day Free Trial														3.89	3.52	3.15	3.10	2.80

Competitive Comparison of Devyser Diagnostics AB's Cash-to-Debt

For the Diagnostics & Research subindustry, Devyser Diagnostics AB's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Devyser Diagnostics AB's Cash-to-Debt Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Devyser Diagnostics AB's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Devyser Diagnostics AB's Cash-to-Debt falls into.

Devyser Diagnostics AB Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Devyser Diagnostics AB's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	23.503	/	(1.564	+	5.122)
	=	3.52

Devyser Diagnostics AB's Cash to Debt Ratio for the quarter that ended in Sep. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	15.097	/	(1.207	+	4.184)
	=	2.80

Devyser Diagnostics AB (FRA:OL0) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Devyser Diagnostics AB Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Devyser Diagnostics AB's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Devyser Diagnostics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Devyser Diagnostics AB (FRA:OL0) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

DVYSR:Sweden

Address

Instrumentvagen 19, Hagersten, SWE, 126 53

Website

https://www.devyser.com

Devyser Diagnostics AB develops, manufactures and sells diagnostic solutions and analysis services to clinical laboratories in more than 65 countries. The products are used for advanced genetic testing in the hereditary disease, oncology and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.

Devyser Diagnostics AB Headlines

No Headlines